CTBP2P10

Across TCGA pan-cancer cohorts, CTBP2P10 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated CTBP2P10 data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher CTBP2P10 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CTBP2P10 expression acts as an unfavorable survival marker.

ESCA, BRCA, and KICH are the cancer types where CTBP2P10 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	III,IV	0.260	0.620	<.001	102	view →
BRCA	DFS	Tertile	All	0.140	1.000	.001	45	view →
KICH	OS	Tertile	All	0.155	0.926	<.001	36	view →
DLBC	OS	Tertile	II,III,IV	0.118	0.802	.025	36	view →
SARC	OS	Tertile	All	0.133	0.860	<.001	27	view →
LUAD	DFS	Tertile	All	0.176	0.658	.003	24	view →
THYM	DFS	Tertile	II,III,IV	0.172	0.747	.005	18	view →
SKCM	OS	Tertile	II,III,IV	0.137	0.394	.039	3	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

CTBP2P10–ESCA (OS)

Open the ESCA breakdown →